Literature DB >> 11196643

A role for ghrelin in the central regulation of feeding.

M Nakazato1, N Murakami, Y Date, M Kojima, H Matsuo, K Kangawa, S Matsukura.   

Abstract

Ghrelin is an acylated peptide that stimulates the release of growth hormone from the pituitary. Ghrelin-producing neurons are located in the hypothalamus, whereas ghrelin receptors are expressed in various regions of the brain, which is indicative of central-and as yet undefined-physiological functions. Here we show that ghrelin is involved in the hypothalamic regulation of energy homeostasis. Intracerebroventricular injections of ghrelin strongly stimulated feeding in rats and increased body weight gain. Ghrelin also increased feeding in rats that are genetically deficient in growth hormone. Anti-ghrelin immunoglobulin G robustly suppressed feeding. After intracerebroventricular ghrelin administration, Fos protein, a marker of neuronal activation, was found in regions of primary importance in the regulation of feeding, including neuropeptide Y6 (NPY) neurons and agouti-related protein (AGRP) neurons. Antibodies and antagonists of NPY and AGRP abolished ghrelin-induced feeding. Ghrelin augmented NPY gene expression and blocked leptin-induced feeding reduction, implying that there is a competitive interaction between ghrelin and leptin in feeding regulation. We conclude that ghrelin is a physiological mediator of feeding, and probably has a function in growth regulation by stimulating feeding and release of growth hormone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11196643     DOI: 10.1038/35051587

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  750 in total

1.  The emerging science of body weight regulation and its impact on obesity treatment.

Authors:  Judith Korner; Louis J Aronne
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Authors:  Carrie Yuen Yee Cheng; Jessica Yan Shuen Chu; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 3.  Clinical application of ghrelin in the field of surgery.

Authors:  Shuji Takiguchi; Kohei Murakami; Yoshitomo Yanagimoto; Akihiro Takata; Yasuhiro Miyazaki; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

4.  Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers.

Authors:  Shuji Takiguchi; Shinichi Adachi; Kazuyoshi Yamamoto; Eiichi Morii; Hiroshi Miyata; Kiyokazu Nakajima; Makoto Yamasaki; Kenji Kangawa; Masaki Mori; Yuichiro Doki
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

5.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 6.  Ghrelin: new molecular pathways modulating appetite and adiposity.

Authors:  Ruben Nogueiras; Lynda M Williams; Carlos Dieguez
Journal:  Obes Facts       Date:  2010-10-04       Impact factor: 3.942

7.  Ghrelin and Helicobacter pylori.

Authors:  C D R Murray; A V Emmanuel
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 8.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 9.  Helicobacter pylori infection and extragastric disorders in children: a critical update.

Authors:  Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.

Authors:  A Gambineri; U Pagotto; M Tschöp; V Vicennati; E Manicardi; A Carcello; M Cacciari; R De Iasio; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.